Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Pituitary|May 23, 2026
Prolactinoma-associated headache: Clinical and radiological correlates and long-term outcomesLukas Andereggen, Christoph Schankin, Philipp Schuetz, et al.
The Journal of Clinical Endocrinology and Metabolism|June 26, 2018
IL-1 Antagonism in Men With Metabolic Syndrome and Low Testosterone: A Randomized Clinical TrialFahim Ebrahimi, Sandrine A Urwyler, Sven Straumann, et al.
The European Respiratory Journal|December 23, 2018
Fibroblast growth factor 21 predicts outcome in community-acquired pneumonia: secondary analysis of two randomised controlled trialsFahim Ebrahimi, Carole Wolffenbuttel, Claudine A Blum, et al.
Frontiers in Endocrinology|March 7, 2022
Machine Learning for Outcome Prediction in First-Line Surgery of ProlactinomasMarkus Huber, Markus M Luedi, Gerrit A Schubert, et al.
Neuroradiology|August 3, 2011
Selective inferior petrosal sinus sampling without venous outflow diversion in the detection of a pituitary adenoma in Cushing's syndromeLukas Andereggen, Gerhard Schroth, Jan Gralla, et al.
The Journal of Clinical Endocrinology and Metabolism|July 24, 2025
Congenital hyperinsulinemic hypoglycemia with a new HADH mutation and pancreatic overexpression of GLP-1 receptorsAndrea Widmer, Urs Zumsteg, Gabor Szinnai, et al.
Frontiers in Surgery|March 28, 2024
Gender-specific prolactin thresholds to determine prolactinoma size: a novel Bayesian approach and its clinical utilityMarkus Huber, Markus M Luedi, Gerrit A Schubert, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2026
68Ga-DOTA-exendin-4 PET/CT for Insulinoma Localization in Patients with Negative or Inconclusive Conventional ImagingJulia G Fricke, Katharina Laubner, Manuela Schildmeijer, et al.
Journal of Neuroendocrinology|March 16, 2023
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinomaHalfdan Sorbye, Enrique Grande, Marianne Pavel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 2, 2017
Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging StudyGuillaume P Nicolas, Nils Schreiter, Felix Kaul, et al.
Pageof 18